PT Charlie Hospital Semarang Tbk (IDX: RSCH)

RSCH Income Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	47,332	42,160	33,033	35,558	13,264
Revenue Growth (YoY)	43.29%	27.63%	-7.10%	168.08%	-
Cost of Revenue	32,596	30,916	29,841	20,256	9,173
Gross Profit	14,736	11,244	3,193	15,302	4,091
Selling, General & Admin	9,526	8,937	8,049	7,982	4,374
Other Operating Expenses	1,651	1,116	1,249	1,432	1,172
Operating Expenses	13,857	12,518	11,988	11,781	7,995
Operating Income	879.61	-1,274	-8,796	3,520	-3,904
Interest & Investment Income	40.45	43.25	33.57	8.91	2.5
Other Non Operating Income (Expenses)	-33.42	-81.87	-152.77	21.43	18.3
Pretax Income	883.98	-1,312	-8,915	3,550	-3,883
Income Tax Expense	98.01	-200.68	-1,560	810.09	-
Net Income	785.97	-1,112	-7,355	2,740	-3,883
Net Income to Common	785.97	-1,112	-7,355	2,740	-3,883
Shares Outstanding (Basic)	2,897	2,303	1,000	1,000	49
Shares Outstanding (Diluted)	2,897	2,303	1,000	1,000	49
Shares Change (YoY)	189.72%	130.33%	-	1923.39%	-
EPS (Basic)	0.27	-0.48	-7.35	2.74	-78.57
EPS (Diluted)	0.27	-0.48	-7.35	2.74	-78.57
Free Cash Flow	-46,002	-62,216	-16,095	-12,011	-8,979
Free Cash Flow Per Share	-15.88	-27.01	-16.09	-12.01	-181.68
Gross Margin	31.13%	26.67%	9.66%	43.03%	30.84%
Operating Margin	1.86%	-3.02%	-26.63%	9.90%	-29.43%
Profit Margin	1.66%	-2.64%	-22.26%	7.71%	-29.27%
Free Cash Flow Margin	-97.19%	-147.57%	-48.72%	-33.78%	-67.69%
EBITDA	6,960	4,465	-3,287	7,916	82.86
EBITDA Margin	14.71%	10.59%	-9.95%	22.26%	0.62%
D&A For EBITDA	6,081	5,739	5,509	4,396	3,987
EBIT	879.61	-1,274	-8,796	3,520	-3,904
EBIT Margin	1.86%	-3.02%	-26.63%	9.90%	-29.43%
Effective Tax Rate	11.09%	-	-	22.82%	-

Source: S&P Capital IQ. Standard template. Financial Sources.